Psödotümör Serebri Sendromu’nda Klinik Özellikler: 60 Hastanın Retrospektif Değerlendirilmesi

Amaç: Psödotümör serebri sendromu (PTSS) tanısı ile izlenen hastaların demografik, klinik ve radyolojik özelliklerinin değerlendirmektir.Gereç ve Yöntem: 2014-2018 yılları arasında, baş ağrısı polikliniğinde takip edilen altmış olgunun etiyolojik, semptom, oftalmolojik, radyolojik vetedavi verileri retrospektif olarak incelendi.Bulgular: Çalışmaya yaş ortalaması 33,70±9,17 olan 54 kadın, 36,50±12,37 olan 6 erkek hasta alındı. Ortalama hastalık süresi 8,91±12,73 ayve ortalama vücut kitle indeksi değeri 30,43±5,27 idi. Etiyolojik olarak %73,3’ü primer, %26,7’si sekonder nedenli idi. Hastaların %91,7’nde başağrısı, %65’de tinnitus, %16,7’nde diplopi ve tamamında papil ödem vardı. Manyetik rezonans görüntülemede 26 hastada perioptik subaraknoidboşluğun genişlemesi, 3 hastada posterior globda düzleşme, 1 hastada Arnold-Chiari malformasyonu, 9 hastada empty sella izlendi. Tedavide 43hasta asetozolamid, 13 hasta asetozolamid ve topiramat, 2 hasta asetozolamid,furosemid ve topiramat, 1 hasta topiramat kullandı. Bir hastaya optiksinir fenestrasyonu yapıldı.Sonuç: Klinik ve nörogörüntüleme bulgularının güncellenmesi, PTSS tanısına daha kapsamlı bir yaklaşım getirmiştir. Ancak PTSS’nun patofizyolojisihalen tam olarak aydınlatılamamıştır. Bu konuda yapılacak araştırmalar, daha etkin tanı ve tedavi yöntemlerinin geliştirilmesini sağlayacaktır.

Clinical Features of Pseudotumour Cerebri Syndrome Syndrome: A Retrospective Evaluation of 60 Patients

Objectives: To evaluate the demographic, clinical and radiological characteristics of the patients who are followed up with the diagnosis of pseudotumour cerebri syndrome (PTCS). Materials and Methods: The etiological, symptomatic, ophtalmologic, radiological and treatment data of sixty cases that were followed up at the outpatient headache clinic between 2014 and 2018 were retrospectively analyzed. Results: Fifty-four female patients having an average age of (36.50±12.37) and 6 male patients having an average age of (33.70±9.17) were included in the study. Mean disease period was 8.91±12.73 months and mean body mass index value was 30.43±5.27. Etiologically, it was due to primary (73.3%) or secondary (26.7%) causes. Headache was present in 91.7% of the patients, tinnitus in 65%, diplopia in 16.7% and papiloedema was present in all the patients. In magnetic resonance imaging, extension of the perioptic subarachnoid space was observed in 26 patients, flattening in the posterior globe in 3 patients, Arnold-Chiari malformation in 1 patient, and empty sella in 9 patients. In the treatment, 43 patients used acetazolamide, 13 patients used acetazolamide and topiramate, 2 patients used acetazolamide, furosemide and topiramate, and 1 patient used topiramate. Optic nerve fenestration was applied to 1 patient. Conclusion: Update of the clinical and neuroimaging findings has brought a more detailed approach for the PTCS diagnosis. However, the pathophysiology of PTSS remains unclear. Researches on this regard will enable the development of more effective diagnosis and treatment methods.

PDF

___

1. Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32:363- 396.
2. De Simone R, Ranieri A, Montella S, et al. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2014;82:1011-1012.
3. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159-1165. 4. McGeeney BE, Friedman DI. Pseudotumor cerebri pathophysiology. Headache. 2014;54:445-458.
5. Julayanont P, Karukote A, Ruthirago D, et al. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects. J Pain Res. 2016;9:87-99.
6. Thurtell MJ, Bruce BB, Newman NJ, et al. An update on idiopathic intracranial hypertension. Rev Neurol Dis. 2010 Spring-Summer;7:e56-68.
7. Headache Classification Committee of the International Headache Society (IHS). The International Classification of HeadacheDisorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808.
8. Mallery RM, Friedman DI, Liu GT. Headache and the pseudotumor cerebri syndrome. Curr Pain Headache Rep. 2014;18:446.
9. Lim M, Kurian M, Penn A, et al. Visual failure without headache in idiopathic intracranial hypertension. Arch Dis Child. 2005;90:206-210.
10. Eren Y, Kabataş N, Güngör Yavaşoğlu N, et al. Idiopathic intracranial hypertension without headache: A case report and literature review. Agri. 2018;30:142-145.
11. Mollan SP, Markey KA, Benzimra JD, et al. A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol. 2014;14:380-390.
12. Skau M, Yri H, Sander B, et al. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2013;251:567-574.
13. Waisbourd M, Leibovitch I, Goldenberg D, et al. OCT assessment of morphological changes of the optic nerve head and macula in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2011;113:839-843.
14. Huang-Link YM, Al-Hawasi A, Oberwahrenbrock T, et al. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Clin Neurol Neurosurg. 2015;130:122-127.
15. Eren Y, Kabatas N, Guven H, et al. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension. Acta Neurol Belg. 2018;17.
16. Akçakaya NH, Akçakaya MO, Sencer A. İdiyopatik İntrakraniyal Hipertansiyon: Tanı ve Tedavi Yaklaşımı Turk J Neurol 2017;23:43-50
17. Bidot S, Saindane AM, Peragallo JH, et al. Brain Imaging in Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2015;35:400-411.